These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 36038111)

  • 1. Dualistic classification of high grade serous ovarian carcinoma has its root in spatial heterogeneity.
    Sun T; Zhang Z; Tian L; Zheng Y; Wu L; Guo Y; Li X; Li Y; Shen H; Lai Y; Liu J; Cui H; He S; Ren Y; Yang G
    J Adv Res; 2023 Jun; 48():213-225. PubMed ID: 36038111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic heterogeneity and evolutionary history of high-grade ovarian carcinoma and matched distant metastases.
    Masoodi T; Siraj S; Siraj AK; Azam S; Qadri Z; Parvathareddy SK; Tulbah A; Al-Dayel F; AlHusaini H; AlOmar O; Al-Badawi IA; Alkuraya FS; Al-Kuraya KS
    Br J Cancer; 2020 Apr; 122(8):1219-1230. PubMed ID: 32099096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis.
    Schwarz RF; Ng CK; Cooke SL; Newman S; Temple J; Piskorz AM; Gale D; Sayal K; Murtaza M; Baldwin PJ; Rosenfeld N; Earl HM; Sala E; Jimenez-Linan M; Parkinson CA; Markowetz F; Brenton JD
    PLoS Med; 2015 Feb; 12(2):e1001789. PubMed ID: 25710373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification of High-Grade Serous Ovarian Carcinoma by Epithelial-to-Mesenchymal Transition Signature and Homologous Recombination Repair Genes.
    Sohn MH; Kim SI; Shin JY; Kim HS; Chung HH; Kim JW; Lee M; Seo JS
    Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing mutation frequencies for homologous recombination genes in uterine serous and high-grade serous ovarian carcinomas: A case for homologous recombination deficiency testing in uterine serous carcinoma.
    Wallbillich JJ; Morris RT; Ali-Fehmi R
    Gynecol Oncol; 2020 Nov; 159(2):381-386. PubMed ID: 32900500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next-generation sequencing shows the genomic features of ovarian clear cell cancer and compares the genetic architectures of high-grade serous ovarian cancer and clear cell carcinoma in ovarian and endometrial tissues.
    Gan M; Tai Z; Yu Y; Zhang C; Xu J
    PeerJ; 2023; 11():e14653. PubMed ID: 36721777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer.
    Xu J; Fang Y; Chen K; Li S; Tang S; Ren Y; Cen Y; Fei W; Zhang B; Shen Y; Lu W
    Clin Cancer Res; 2022 Aug; 28(16):3590-3602. PubMed ID: 35675036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic Mutational Profile of High-Grade Serous Ovarian Carcinoma and Triple-Negative Breast Carcinoma in Young and Elderly Patients: Similarities and Divergences.
    Serio PAMP; de Lima Pereira GF; Katayama MLH; Roela RA; Maistro S; Folgueira MAAK
    Cells; 2021 Dec; 10(12):. PubMed ID: 34944094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of high-grade serous ovarian cancers occurring in younger and older women.
    Filippova OT; Selenica P; Pareja F; Vahdatinia M; Zhu Y; Pei X; Riaz N; Long Roche K; Chi DS; Abu-Rustum NR; Ellenson LH; Reis-Filho JS; Zamarin D; Weigelt B
    Gynecol Oncol; 2021 May; 161(2):545-552. PubMed ID: 33674143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic heterogeneity after first-line chemotherapy in high-grade serous ovarian cancer.
    Lambrechts S; Smeets D; Moisse M; Braicu EI; Vanderstichele A; Zhao H; Van Nieuwenhuysen E; Berns E; Sehouli J; Zeillinger R; Darb-Esfahani S; Cacsire Castillo-Tong D; Lambrechts D; Vergote I
    Eur J Cancer; 2016 Jan; 53():51-64. PubMed ID: 26693899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular matrix in high-grade serous ovarian cancer: Advances in understanding of carcinogenesis and cancer biology.
    Brown Y; Hua S; Tanwar PS
    Matrix Biol; 2023 Apr; 118():16-46. PubMed ID: 36781087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-Cell RNA-Sequencing Atlas Reveals the Tumor Microenvironment of Metastatic High-Grade Serous Ovarian Carcinoma.
    Deng Y; Tan Y; Zhou D; Bai Y; Cao T; Zhong C; Huang W; Ou Y; Guo L; Liu Q; Yin D; Chen L; Luo X; Sun D; Sheng X
    Front Immunol; 2022; 13():923194. PubMed ID: 35935940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis comparison between small cell carcinoma of ovary and high-grade serous ovarian cancer: A retrospective observational cohort study.
    Hu D; Ma D; Zhang ZJ; Zhang Y; Huang K; Li X
    Front Endocrinol (Lausanne); 2023; 14():1103429. PubMed ID: 36742399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of proteomics with CT-based qualitative and radiomic features in high-grade serous ovarian cancer patients: an exploratory analysis.
    Beer L; Sahin H; Bateman NW; Blazic I; Vargas HA; Veeraraghavan H; Kirby J; Fevrier-Sullivan B; Freymann JB; Jaffe CC; Brenton J; Miccó M; Nougaret S; Darcy KM; Maxwell GL; Conrads TP; Huang E; Sala E
    Eur Radiol; 2020 Aug; 30(8):4306-4316. PubMed ID: 32253542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatial and temporal intra-tumoral heterogeneity in advanced HGSOC: Implications for surgical and clinical outcomes.
    Cunnea P; Curry EW; Christie EL; Nixon K; Kwok CH; Pandey A; Wulandari R; Thol K; Ploski J; Morera-Albert C; McQuaid S; Lozano-Kuehne J; Clark JJ; Krell J; Stronach EA; McNeish IA; Bowtell DDL; Fotopoulou C
    Cell Rep Med; 2023 Jun; 4(6):101055. PubMed ID: 37220750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of Tumor Heterogeneity in High-Grade Serous Ovarian Cancers.
    Azzalini E; Stanta G; Canzonieri V; Bonin S
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-grade serous ovarian carcinoma organoids as models of chromosomal instability.
    Vias M; Morrill Gavarró L; Sauer CM; Sanders DA; Piskorz AM; Couturier DL; Ballereau S; Hernando B; Schneider MP; Hall J; Correia-Martins F; Markowetz F; Macintyre G; Brenton JD
    Elife; 2023 May; 12():. PubMed ID: 37166279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating single-cell and spatial transcriptomic analysis to unveil heterogeneity in high-grade serous ovarian cancer.
    Luo H; Wang K; Li B
    Front Immunol; 2024; 15():1420847. PubMed ID: 38975339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of ICAM-1 Predicts Poor Survival in High-Grade Serous Ovarian Carcinoma: A Study Based on TCGA and GEO Databases and Tissue Microarray.
    Wang S; Yin C; Zhang Y; Zhang L; Tao L; Liang W; Pang L; Fu R; Ding Y; Li F; Jia W
    Biomed Res Int; 2019; 2019():2867372. PubMed ID: 31312656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of serous tubal intraepithelial carcinoma (STIC) in patients with high grade serous ovarian cancer.
    Byun JM; Cho HJ; Lee DS; Yoon HK; Kim YN; Im DH; Kim DH; Lee KB; Sung MS; Jeong DH
    Taiwan J Obstet Gynecol; 2023 Jan; 62(1):107-111. PubMed ID: 36720520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.